Valassis filed suit in September seeking to back out of its agreement to buy Advo for $1.3 billion. It claimed the company had misrepresented its financial results in the second quarter.
The two companies came to terms after the board of Advo agreed late Monday to drop its asking price to $33 a share from $37, and Valassis acknowledged that it had found no evidence to support its
claim of having been defrauded by Advo.
A person familiar with the transaction said that Valassis had until Feb. 28 to close the deal or two business days after Advo shareholders approve it, whichever comes later.
advertisement
advertisement